Coty/Bottega Veneta
This article was originally published in The Rose Sheet
Executive Summary
Fragrance powerhouse signs deal with luxury lifestyle brand to develop and market a new line of fragrances under the Bottega Veneta name. Long respected for its hand-crafted leather goods, Bottega Veneta was purchased by Gucci in 2001 and came under the creative direction of Tomas Maier, who "has evolved a signature concept of luxury based upon outstanding craftsmanship, innovative design, contemporary functionality and the highest-quality materials," according to Dec. 4 release. Coty CEO Bernd Beetz states: "Bottega Veneta remains one of the world's premier designer labels and architects of fashion. ... The dynamic brand is both a natural fit and winning partner for Coty." Firm notes that Bottega Veneta's global presence in specialty and department stores is complemented by a growing number of its own boutiques
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.